These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 13443)

  • 1. [Pimozide and piportil in the treatment of chronic schizophrenia (preliminary communication)].
    Masiak M; Majczak A; Hascewicz-Rzecka M; Kowalczyk A
    Psychiatr Pol; 1976; 10(6):655-60. PubMed ID: 13443
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pipothiazine (piportil) in the treatment of various forms of schizophrenia].
    Matkowski K; Sep-Kowalikowa B
    Psychiatr Pol; 1979; 13(4):421-3. PubMed ID: 42095
    [No Abstract]   [Full Text] [Related]  

  • 3. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of schizophrenia with imiclopazine, pimozide, imagotan and trifluorperidol. Comparative study].
    Nurowska K; Welbel L
    Psychiatr Pol; 1973; 7(1):57-63. PubMed ID: 4146043
    [No Abstract]   [Full Text] [Related]  

  • 5. An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients.
    Amin MM; Brahm E; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):10-1. PubMed ID: 18753
    [No Abstract]   [Full Text] [Related]  

  • 6. Pimozide as an adjuvant to maintenance therapy in chronic schizophrenia.
    Nakra BR; Wickramasinghe NA
    Pharmatherapeutica; 1980; 2(5):337-40. PubMed ID: 6107933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.
    Denijs EL; Vereecken JL
    Psychiatr Neurol Neurochir; 1973; 76(1):47-59. PubMed ID: 4699105
    [No Abstract]   [Full Text] [Related]  

  • 8. [Haloperidol decanoate in replacing combinations of antipsychotic agents in the treatment of chronic schizophrenics].
    Youssef HA
    Acta Psiquiatr Psicol Am Lat; 1984 Dec; 30(4):297-304. PubMed ID: 6152573
    [No Abstract]   [Full Text] [Related]  

  • 9. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
    Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
    [No Abstract]   [Full Text] [Related]  

  • 10. Clomipramine treatment of delusional disorder, somatic type.
    Wada T; Kawakatsu S; Nadaoka T; Okuyama N; Otani K
    Int Clin Psychopharmacol; 1999 May; 14(3):181-3. PubMed ID: 10435772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow.
    Hollister LE
    Adv Biochem Psychopharmacol; 1974; 9(0):667-73. PubMed ID: 4151921
    [No Abstract]   [Full Text] [Related]  

  • 12. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
    Friedman J; Ault K; Powchik P
    Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
    [No Abstract]   [Full Text] [Related]  

  • 13. A three-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia.
    Abuzzahab FS; Zimmermann RL
    Psychopharmacol Bull; 1976 Apr; 12(2):26-7. PubMed ID: 769023
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluations of social functioning in a 3-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia [proceedings].
    Abuzzahab FS
    Psychopharmacol Bull; 1977 Jan; 13(1):71-3. PubMed ID: 319477
    [No Abstract]   [Full Text] [Related]  

  • 15. Pimozide (R6238) in chronic schizophrenia: double blind trial.
    Gowardman M; Barrer B; Brown RA
    N Z Med J; 1973 Dec; 78(504):487-91. PubMed ID: 4591853
    [No Abstract]   [Full Text] [Related]  

  • 16. [EEG records and effects of phenothiazine treatment in patients with paranoid schizophrenia].
    Ekiert H; Gogol Z; Welbel L; Kazubska M
    Psychiatr Pol; 1977; 11(3):325-33. PubMed ID: 19798
    [No Abstract]   [Full Text] [Related]  

  • 17. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
    Wilson LG; Roberts RW; Gerber CJ; Johnson MH
    J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A series of multicentric pilot trials with pimozide in psychiatric practice. IV. Pimozide in the treatment of patients with paranoid symptomatology.
    Amery W; Boom AJ; Huisman NG; Kuipers H; van der Wiel HJ; Reyntjens A
    Acta Psychiatr Belg; 1972 Nov; 72(6):677-84. PubMed ID: 4679634
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients.
    Claghorn JL
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):1005-9. PubMed ID: 4214658
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary experience in the treatment of schizophrenia with pipothiazine and its derivatives.
    Faltus F; Marecek P; Soucek K
    Act Nerv Super (Praha); 1975 Sep; 17(3):204. PubMed ID: 883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.